SCIENCE TO
MEDICINE

At Regeneron, we move science to medicine because our world is meant for more.

See what drives us

George’s Five
Principles
for Radical
Innovation

Pioneering a new era in biopharmaceutical innovation

Learn more about Radical Innovation for Humanity

EYE ON
THE EXPERTS

Sharing our scientific approach and lessons learned as we look toward the future.

Learn more from our experts

SCIENCE WITH PURPOSE

Our 2024 Responsibility Report captures the work, values and progress driving Regeneron forward.

Learn how we're doing well by doing good

SUPPORTING
FUTURE STEM
TALENT

The Regeneron Science Talent Search and International Science and Engineering Fair have provided education and career pathways for ~2.4M STEM students since 2020.

Learn how we support future STEM talent

At Regeneron, we move science to medicine because our world is meant for more.

See what drives us

Pioneering a new era in biopharmaceutical innovation

Learn more about Radical Innovation for Humanity

Sharing our scientific approach and lessons learned as we look toward the future.

Learn more from our experts

Our 2024 Responsibility Report captures the work, values and progress driving Regeneron forward.

Learn how we're doing well by doing good

The Regeneron Science Talent Search and International Science and Engineering Fair have provided education and career pathways for ~2.4M STEM students since 2020.

Learn how we support future STEM talent

Press releases for investors and media

Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 Head-to-Head Respiratory Trial

Dupixent® (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color

Stay current on Regeneron news and company updates

Visit our newsroom

We aim to push the bounds of science to make

LIFE-CHANGING MEDICINES

Len and George discussing 2023 accomplishments and vision.

We’re driven by the pursuit of scientific breakthroughs, seeking innovative solutions for people facing serious diseases. From biologics to genetic medicines, our journey turns cutting-edge science into transformative medicine, redefining excellence and efficiency in research and development.

Learn about our research and development efforts

We're guided by our philosophy of

doing well by doing good

We’re dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us.

Learn about our approach to corporate responsibility

Join the brightest, most passionate innovators in science. Find your next opportunity by applying for jobs and internships at Regeneron today.

Join our team

Our journey of discovery continues as we strive to transform the lives of people with serious diseases. Discover more about our clinical trials or locate a relevant trial near you.

Explore our clinical trials